FibroGen, Inc.
CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
Last updated:
Abstract:
The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
16 Dec 2019
Issue date:
16 Apr 2020